Bursa today announced that effective 9:00am, 31 December 2024 (Tuesday), Sunzen Biotech Bhd will be traded and quoted under its new name Sunzen Group Bhd while the stock code and acronym remain unchanged, according to a Bursa-issued media notification dated Dec 27.

Meanwhile, the warrants of Sunzen Group's underlying securities will be renamed to Sunzen Group Berhad – Warrants C2022/2027, from Sunzen Biotech Berhad – Warrants C2022/2027.

On Dec 19, during the group's 19th Annual General Meeting (AGM), shareholders approved a special resolution to rename the company from "Sunzen Biotech Berhad" to "Sunzen Group Berhad," signalling the group's venturing into diversified operations encompassing health, medical devices and services, and loan financing, according to a Bursa filing dated Dec 19.

Group Managing Director (MD) of Sunzen Group Teo Yek Ming commented, "The adoption of the new name, Sunzen Group Berhad, symbolises our growth beyond the biotechnology sector, positioning us as a multifaceted organisation ready to deliver greater value to our shareholders."

"The Group will continually explore new opportunities across various industries, aiming to establish individual ecosystems within the fields of health and wellness products, medical devices and services, as well as loan financing, striving to become a sustainable and long-term enterprise." the MD added.